nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—breast cancer—Betamethasone—hematologic cancer	0.117	0.5	CpDpCtD
Estradiol—breast cancer—Dexamethasone—hematologic cancer	0.117	0.5	CpDpCtD
Estradiol—UGT1A1—hematologic cancer	0.0553	0.243	CbGaD
Estradiol—SLC22A1—hematologic cancer	0.0445	0.196	CbGaD
Estradiol—AR—hematologic cancer	0.0396	0.174	CbGaD
Estradiol—ABCG2—hematologic cancer	0.0311	0.137	CbGaD
Estradiol—ESR1—hematologic cancer	0.0305	0.134	CbGaD
Estradiol—ALB—hematologic cancer	0.0136	0.0596	CbGaD
Estradiol—CYP1B1—Procarbazine—hematologic cancer	0.0132	0.0401	CbGbCtD
Estradiol—ABCC10—Daunorubicin—hematologic cancer	0.013	0.0395	CbGbCtD
Estradiol—ABCB1—hematologic cancer	0.0129	0.0569	CbGaD
Estradiol—ABCC10—Cytarabine—hematologic cancer	0.0115	0.0349	CbGbCtD
Estradiol—SLC22A3—Melphalan—hematologic cancer	0.0109	0.033	CbGbCtD
Estradiol—Testosterone—Prednisolone—hematologic cancer	0.00988	1	CrCrCtD
Estradiol—AOX1—Mercaptopurine—hematologic cancer	0.00952	0.029	CbGbCtD
Estradiol—CYP1B1—Daunorubicin—hematologic cancer	0.00706	0.0215	CbGbCtD
Estradiol—ABCC10—Gemcitabine—hematologic cancer	0.00697	0.0212	CbGbCtD
Estradiol—SLCO1A2—Chlorambucil—hematologic cancer	0.00633	0.0193	CbGbCtD
Estradiol—ABCG2—Clofarabine—hematologic cancer	0.00572	0.0174	CbGbCtD
Estradiol—ABCC10—Vincristine—hematologic cancer	0.00543	0.0165	CbGbCtD
Estradiol—ABCC10—Etoposide—hematologic cancer	0.00498	0.0151	CbGbCtD
Estradiol—SLC22A2—Daunorubicin—hematologic cancer	0.00455	0.0138	CbGbCtD
Estradiol—CYP1B1—Dasatinib—hematologic cancer	0.00434	0.0132	CbGbCtD
Estradiol—CYP1B1—Mitoxantrone—hematologic cancer	0.00429	0.0131	CbGbCtD
Estradiol—UGT1A1—Nilotinib—hematologic cancer	0.00425	0.0129	CbGbCtD
Estradiol—SLC22A2—Cytarabine—hematologic cancer	0.00401	0.0122	CbGbCtD
Estradiol—SLC22A2—Cladribine—hematologic cancer	0.00379	0.0115	CbGbCtD
Estradiol—SLC22A3—Irinotecan—hematologic cancer	0.00367	0.0112	CbGbCtD
Estradiol—SLC22A1—Cytarabine—hematologic cancer	0.00348	0.0106	CbGbCtD
Estradiol—SLC22A2—Imatinib—hematologic cancer	0.00348	0.0106	CbGbCtD
Estradiol—CYP1A2—Anagrelide—hematologic cancer	0.00341	0.0104	CbGbCtD
Estradiol—CYP1A1—Methoxsalen—hematologic cancer	0.0034	0.0104	CbGbCtD
Estradiol—ABCC10—Doxorubicin—hematologic cancer	0.00339	0.0103	CbGbCtD
Estradiol—ABCG2—Daunorubicin—hematologic cancer	0.00336	0.0102	CbGbCtD
Estradiol—SLC22A1—Cladribine—hematologic cancer	0.00329	0.01	CbGbCtD
Estradiol—SLCO1C1—Methotrexate—hematologic cancer	0.00329	0.01	CbGbCtD
Estradiol—ABCC10—Methotrexate—hematologic cancer	0.00329	0.01	CbGbCtD
Estradiol—CYP1A1—Bortezomib—hematologic cancer	0.00324	0.00985	CbGbCtD
Estradiol—SLC22A3—Vincristine—hematologic cancer	0.00321	0.00977	CbGbCtD
Estradiol—AOX1—Methotrexate—hematologic cancer	0.00311	0.00947	CbGbCtD
Estradiol—CYP1A1—Daunorubicin—hematologic cancer	0.0031	0.00942	CbGbCtD
Estradiol—SLC22A1—Imatinib—hematologic cancer	0.00302	0.0092	CbGbCtD
Estradiol—SLC22A8—Mercaptopurine—hematologic cancer	0.00302	0.00919	CbGbCtD
Estradiol—ESR2—ovarian follicle—hematologic cancer	0.00302	0.104	CbGeAlD
Estradiol—UGT1A1—Irinotecan—hematologic cancer	0.00292	0.00888	CbGbCtD
Estradiol—ABCG2—Teniposide—hematologic cancer	0.00292	0.00887	CbGbCtD
Estradiol—CYP1A1—Thalidomide—hematologic cancer	0.00282	0.00858	CbGbCtD
Estradiol—ABCG2—Cladribine—hematologic cancer	0.0028	0.0085	CbGbCtD
Estradiol—ABCG2—Imatinib—hematologic cancer	0.00257	0.00782	CbGbCtD
Estradiol—CYP1A1—Dacarbazine—hematologic cancer	0.00243	0.00738	CbGbCtD
Estradiol—SLCO1A2—Prednisolone—hematologic cancer	0.00239	0.00728	CbGbCtD
Estradiol—UGT1A1—Etoposide—hematologic cancer	0.00234	0.00711	CbGbCtD
Estradiol—ABCG2—Nilotinib—hematologic cancer	0.00234	0.00711	CbGbCtD
Estradiol—SLCO1A2—Prednisone—hematologic cancer	0.00226	0.00687	CbGbCtD
Estradiol—CYP1B1—Dexamethasone—hematologic cancer	0.00222	0.00677	CbGbCtD
Estradiol—CYP2C9—Bexarotene—hematologic cancer	0.00213	0.00647	CbGbCtD
Estradiol—ESR1—ovarian follicle—hematologic cancer	0.00207	0.071	CbGeAlD
Estradiol—ABCG2—Dasatinib—hematologic cancer	0.00206	0.00628	CbGbCtD
Estradiol—ABCB1—Lenalidomide—hematologic cancer	0.00206	0.00628	CbGbCtD
Estradiol—ABCG2—Mitoxantrone—hematologic cancer	0.00204	0.0062	CbGbCtD
Estradiol—SLCO1B1—Irinotecan—hematologic cancer	0.00202	0.00615	CbGbCtD
Estradiol—CYP3A7—Ifosfamide—hematologic cancer	0.00199	0.00605	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00199	0.00605	CbGbCtD
Estradiol—SLC22A2—Vinblastine—hematologic cancer	0.00193	0.00588	CbGbCtD
Estradiol—CYP1A1—Dasatinib—hematologic cancer	0.00191	0.0058	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0019	0.00578	CbGbCtD
Estradiol—CYP3A7—Imatinib—hematologic cancer	0.0019	0.00578	CbGbCtD
Estradiol—CYP2C8—Bortezomib—hematologic cancer	0.00187	0.00569	CbGbCtD
Estradiol—CYP3A5—Daunorubicin—hematologic cancer	0.00186	0.00566	CbGbCtD
Estradiol—CYP1B1—Doxorubicin—hematologic cancer	0.00184	0.00561	CbGbCtD
Estradiol—SLCO1B3—Methotrexate—hematologic cancer	0.00184	0.00559	CbGbCtD
Estradiol—CYP1A2—Carmustine—hematologic cancer	0.00179	0.00544	CbGbCtD
Estradiol—SLC22A2—Cisplatin—hematologic cancer	0.00177	0.00539	CbGbCtD
Estradiol—ALB—Imatinib—hematologic cancer	0.00177	0.00539	CbGbCtD
Estradiol—CYP2C9—Idarubicin—hematologic cancer	0.00176	0.00536	CbGbCtD
Estradiol—SLC22A11—Methotrexate—hematologic cancer	0.0017	0.00516	CbGbCtD
Estradiol—CYP3A5—Thalidomide—hematologic cancer	0.00169	0.00515	CbGbCtD
Estradiol—CYP3A5—Teniposide—hematologic cancer	0.00162	0.00491	CbGbCtD
Estradiol—ABCG2—Irinotecan—hematologic cancer	0.00161	0.00488	CbGbCtD
Estradiol—CYP2C19—Bortezomib—hematologic cancer	0.00157	0.00477	CbGbCtD
Estradiol—CYP1A2—Methoxsalen—hematologic cancer	0.00152	0.00463	CbGbCtD
Estradiol—CYP3A5—Ifosfamide—hematologic cancer	0.00149	0.00454	CbGbCtD
Estradiol—CYP1A2—Bortezomib—hematologic cancer	0.00145	0.0044	CbGbCtD
Estradiol—ESRRB—gonad—hematologic cancer	0.00144	0.0496	CbGeAlD
Estradiol—CYP2C8—Ifosfamide—hematologic cancer	0.00143	0.00436	CbGbCtD
Estradiol—CYP3A5—Imatinib—hematologic cancer	0.00142	0.00433	CbGbCtD
Estradiol—SLCO1A2—Dexamethasone—hematologic cancer	0.00141	0.00429	CbGbCtD
Estradiol—ABCG2—Vincristine—hematologic cancer	0.0014	0.00427	CbGbCtD
Estradiol—CYP1A2—Daunorubicin—hematologic cancer	0.00138	0.00421	CbGbCtD
Estradiol—CYP2C19—Thalidomide—hematologic cancer	0.00137	0.00416	CbGbCtD
Estradiol—CYP1A2—Alitretinoin—hematologic cancer	0.00136	0.00412	CbGbCtD
Estradiol—ABCG2—Cisplatin—hematologic cancer	0.00131	0.00398	CbGbCtD
Estradiol—CYP2C9—Bortezomib—hematologic cancer	0.0013	0.00397	CbGbCtD
Estradiol—CYP2C19—Teniposide—hematologic cancer	0.0013	0.00396	CbGbCtD
Estradiol—ABCG2—Etoposide—hematologic cancer	0.00129	0.00391	CbGbCtD
Estradiol—CYP1A2—Thalidomide—hematologic cancer	0.00126	0.00383	CbGbCtD
Estradiol—CYP2C8—Nilotinib—hematologic cancer	0.00124	0.00379	CbGbCtD
Estradiol—CYP3A4—Bexarotene—hematologic cancer	0.00124	0.00376	CbGbCtD
Estradiol—ABCB1—Daunorubicin—hematologic cancer	0.00121	0.00368	CbGbCtD
Estradiol—CYP2C19—Ifosfamide—hematologic cancer	0.0012	0.00366	CbGbCtD
Estradiol—CYP3A7—Irinotecan—hematologic cancer	0.00119	0.00361	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00119	0.00361	CbGbCtD
Estradiol—ABCB1—Alitretinoin—hematologic cancer	0.00119	0.00361	CbGbCtD
Estradiol—ALB—Prednisone—hematologic cancer	0.00117	0.00355	CbGbCtD
Estradiol—CYP3A4—Busulfan—hematologic cancer	0.00115	0.0035	CbGbCtD
Estradiol—CYP3A4—Lomustine—hematologic cancer	0.00115	0.0035	CbGbCtD
Estradiol—CYP2C19—Imatinib—hematologic cancer	0.00115	0.00349	CbGbCtD
Estradiol—CYP3A5—Dasatinib—hematologic cancer	0.00114	0.00348	CbGbCtD
Estradiol—CYP2C9—Thalidomide—hematologic cancer	0.00114	0.00345	CbGbCtD
Estradiol—SLCO1A2—Methotrexate—hematologic cancer	0.00113	0.00345	CbGbCtD
Estradiol—ALB—Irinotecan—hematologic cancer	0.00111	0.00337	CbGbCtD
Estradiol—CYP1A2—Dacarbazine—hematologic cancer	0.00108	0.0033	CbGbCtD
Estradiol—CYP2C9—Teniposide—hematologic cancer	0.00108	0.0033	CbGbCtD
Estradiol—SLCO1B1—Methotrexate—hematologic cancer	0.00107	0.00325	CbGbCtD
Estradiol—CYP1A2—Imatinib—hematologic cancer	0.00106	0.00322	CbGbCtD
Estradiol—ABCG2—Dexamethasone—hematologic cancer	0.00106	0.00322	CbGbCtD
Estradiol—ESRRB—testis—hematologic cancer	0.00104	0.0358	CbGeAlD
Estradiol—CYP3A7—Vincristine—hematologic cancer	0.00104	0.00315	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00104	0.00315	CbGbCtD
Estradiol—CYP3A4—Thiotepa—hematologic cancer	0.00102	0.00312	CbGbCtD
Estradiol—CYP2C9—Ifosfamide—hematologic cancer	0.001	0.00304	CbGbCtD
Estradiol—SLC22A8—Methotrexate—hematologic cancer	0.000987	0.003	CbGbCtD
Estradiol—CYP1A1—Dexamethasone—hematologic cancer	0.000976	0.00297	CbGbCtD
Estradiol—CYP2C9—Imatinib—hematologic cancer	0.000955	0.00291	CbGbCtD
Estradiol—ABCB1—Imatinib—hematologic cancer	0.000927	0.00282	CbGbCtD
Estradiol—CYP3A5—Irinotecan—hematologic cancer	0.000889	0.00271	CbGbCtD
Estradiol—ABCG2—Doxorubicin—hematologic cancer	0.000877	0.00267	CbGbCtD
Estradiol—CYP2C9—Nilotinib—hematologic cancer	0.000868	0.00264	CbGbCtD
Estradiol—CYP1A2—Dasatinib—hematologic cancer	0.000851	0.00259	CbGbCtD
Estradiol—ABCG2—Methotrexate—hematologic cancer	0.00085	0.00258	CbGbCtD
Estradiol—ABCB1—Nilotinib—hematologic cancer	0.000842	0.00256	CbGbCtD
Estradiol—ABCB1—Vinorelbine—hematologic cancer	0.000835	0.00254	CbGbCtD
Estradiol—CYP3A4—Methoxsalen—hematologic cancer	0.000797	0.00242	CbGbCtD
Estradiol—CYP3A7—Dexamethasone—hematologic cancer	0.000781	0.00238	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.000781	0.00238	CbGbCtD
Estradiol—CYP3A5—Vincristine—hematologic cancer	0.000777	0.00237	CbGbCtD
Estradiol—CYP3A4—Bortezomib—hematologic cancer	0.000758	0.00231	CbGbCtD
Estradiol—CYP2C19—Prednisone—hematologic cancer	0.000757	0.0023	CbGbCtD
Estradiol—ABCB1—Dasatinib—hematologic cancer	0.000744	0.00226	CbGbCtD
Estradiol—ABCB1—Mitoxantrone—hematologic cancer	0.000735	0.00224	CbGbCtD
Estradiol—CYP3A4—Daunorubicin—hematologic cancer	0.000725	0.00221	CbGbCtD
Estradiol—GPER1—testis—hematologic cancer	0.000715	0.0246	CbGeAlD
Estradiol—CYP3A5—Etoposide—hematologic cancer	0.000712	0.00217	CbGbCtD
Estradiol—CYP2C8—Etoposide—hematologic cancer	0.000685	0.00208	CbGbCtD
Estradiol—ABCB1—Betamethasone—hematologic cancer	0.000655	0.00199	CbGbCtD
Estradiol—ABCB1—Gemcitabine—hematologic cancer	0.000649	0.00198	CbGbCtD
Estradiol—ABCB1—Prednisolone—hematologic cancer	0.000647	0.00197	CbGbCtD
Estradiol—CYP3A4—Cytarabine—hematologic cancer	0.000639	0.00195	CbGbCtD
Estradiol—CYP3A4—Teniposide—hematologic cancer	0.00063	0.00192	CbGbCtD
Estradiol—ABCB1—Prednisone—hematologic cancer	0.000611	0.00186	CbGbCtD
Estradiol—CYP3A5—Dexamethasone—hematologic cancer	0.000586	0.00178	CbGbCtD
Estradiol—ALB—Methotrexate—hematologic cancer	0.000586	0.00178	CbGbCtD
Estradiol—CYP3A4—Ifosfamide—hematologic cancer	0.000581	0.00177	CbGbCtD
Estradiol—ABCB1—Irinotecan—hematologic cancer	0.000579	0.00176	CbGbCtD
Estradiol—FABP2—lymph node—hematologic cancer	0.000572	0.0196	CbGeAlD
Estradiol—CYP2C8—Dexamethasone—hematologic cancer	0.000563	0.00171	CbGbCtD
Estradiol—CYP3A4—Imatinib—hematologic cancer	0.000555	0.00169	CbGbCtD
Estradiol—CYP1A2—Etoposide—hematologic cancer	0.00053	0.00161	CbGbCtD
Estradiol—CYP3A4—Ruxolitinib—hematologic cancer	0.000523	0.00159	CbGbCtD
Estradiol—GPER1—lymph node—hematologic cancer	0.000518	0.0178	CbGeAlD
Estradiol—ABCB1—Vinblastine—hematologic cancer	0.000515	0.00157	CbGbCtD
Estradiol—ABCB1—Vincristine—hematologic cancer	0.000506	0.00154	CbGbCtD
Estradiol—CYP3A4—Nilotinib—hematologic cancer	0.000505	0.00154	CbGbCtD
Estradiol—CYP3A4—Vinorelbine—hematologic cancer	0.0005	0.00152	CbGbCtD
Estradiol—CYP2C9—Cisplatin—hematologic cancer	0.000486	0.00148	CbGbCtD
Estradiol—CYP2C19—Dexamethasone—hematologic cancer	0.000472	0.00144	CbGbCtD
Estradiol—ABCB1—Cisplatin—hematologic cancer	0.000472	0.00144	CbGbCtD
Estradiol—ABCB1—Etoposide—hematologic cancer	0.000464	0.00141	CbGbCtD
Estradiol—CYP3A4—Triamcinolone—hematologic cancer	0.000458	0.00139	CbGbCtD
Estradiol—CYP3A4—Dasatinib—hematologic cancer	0.000446	0.00136	CbGbCtD
Estradiol—CYP3A4—Mitoxantrone—hematologic cancer	0.000441	0.00134	CbGbCtD
Estradiol—UGT1A1—hematopoietic system—hematologic cancer	0.000434	0.0149	CbGeAlD
Estradiol—ESRRA—blood—hematologic cancer	0.000402	0.0138	CbGeAlD
Estradiol—CYP2C9—Dexamethasone—hematologic cancer	0.000393	0.0012	CbGbCtD
Estradiol—CYP3A4—Betamethasone—hematologic cancer	0.000393	0.00119	CbGbCtD
Estradiol—ESRRA—bone marrow—hematologic cancer	0.000389	0.0134	CbGeAlD
Estradiol—CYP3A4—Prednisolone—hematologic cancer	0.000387	0.00118	CbGbCtD
Estradiol—ABCB1—Dexamethasone—hematologic cancer	0.000381	0.00116	CbGbCtD
Estradiol—CYP3A4—Prednisone—hematologic cancer	0.000366	0.00111	CbGbCtD
Estradiol—ESR2—hematopoietic system—hematologic cancer	0.000364	0.0125	CbGeAlD
Estradiol—SLCO1B3—lung—hematologic cancer	0.000363	0.0125	CbGeAlD
Estradiol—SLCO1B1—hematopoietic system—hematologic cancer	0.000361	0.0124	CbGeAlD
Estradiol—SHBG—hematopoietic system—hematologic cancer	0.000354	0.0122	CbGeAlD
Estradiol—ESRRA—lung—hematologic cancer	0.000352	0.0121	CbGeAlD
Estradiol—CYP3A4—Irinotecan—hematologic cancer	0.000347	0.00106	CbGbCtD
Estradiol—ABCC10—hematopoietic system—hematologic cancer	0.000341	0.0117	CbGeAlD
Estradiol—ESRRA—testis—hematologic cancer	0.000332	0.0114	CbGeAlD
Estradiol—SLCO2B1—hematopoietic system—hematologic cancer	0.00032	0.011	CbGeAlD
Estradiol—ABCB1—Doxorubicin—hematologic cancer	0.000316	0.000962	CbGbCtD
Estradiol—CYP3A4—Vinblastine—hematologic cancer	0.000308	0.000938	CbGbCtD
Estradiol—ABCB1—Methotrexate—hematologic cancer	0.000306	0.000932	CbGbCtD
Estradiol—CYP3A4—Vincristine—hematologic cancer	0.000303	0.000922	CbGbCtD
Estradiol—SLCO1A2—hematopoietic system—hematologic cancer	0.000294	0.0101	CbGeAlD
Estradiol—SLC22A3—hematopoietic system—hematologic cancer	0.000292	0.01	CbGeAlD
Estradiol—UGT1A1—blood—hematologic cancer	0.000288	0.00989	CbGeAlD
Estradiol—SLCO1C1—testis—hematologic cancer	0.000281	0.00965	CbGeAlD
Estradiol—SLC22A8—hematopoietic system—hematologic cancer	0.000281	0.00965	CbGeAlD
Estradiol—CYP3A4—Etoposide—hematologic cancer	0.000278	0.000845	CbGbCtD
Estradiol—ESR2—gonad—hematologic cancer	0.000277	0.00951	CbGeAlD
Estradiol—SHBG—gonad—hematologic cancer	0.000269	0.00925	CbGeAlD
Estradiol—CYP1B1—hematopoietic system—hematologic cancer	0.000268	0.00922	CbGeAlD
Estradiol—AOX1—gonad—hematologic cancer	0.000266	0.00916	CbGeAlD
Estradiol—ABCC10—gonad—hematologic cancer	0.000259	0.00891	CbGeAlD
Estradiol—AR—hematopoietic system—hematologic cancer	0.000254	0.00873	CbGeAlD
Estradiol—ESR1—hematopoietic system—hematologic cancer	0.000249	0.00857	CbGeAlD
Estradiol—ESR2—blood—hematologic cancer	0.000241	0.00829	CbGeAlD
Estradiol—ESRRA—lymph node—hematologic cancer	0.000241	0.00828	CbGeAlD
Estradiol—SLCO1B1—blood—hematologic cancer	0.000239	0.00823	CbGeAlD
Estradiol—SLCO4A1—lung—hematologic cancer	0.000238	0.0082	CbGeAlD
Estradiol—CYP2C19—hematopoietic system—hematologic cancer	0.000235	0.00809	CbGeAlD
Estradiol—SHBG—blood—hematologic cancer	0.000234	0.00806	CbGeAlD
Estradiol—CYP3A4—Dexamethasone—hematologic cancer	0.000228	0.000695	CbGbCtD
Estradiol—SHBG—bone marrow—hematologic cancer	0.000227	0.0078	CbGeAlD
Estradiol—ABCC10—blood—hematologic cancer	0.000226	0.00777	CbGeAlD
Estradiol—SLCO4A1—testis—hematologic cancer	0.000225	0.00773	CbGeAlD
Estradiol—SLC22A3—gonad—hematologic cancer	0.000222	0.00763	CbGeAlD
Estradiol—ABCC10—bone marrow—hematologic cancer	0.000219	0.00752	CbGeAlD
Estradiol—Fulvestrant—ESR1—hematologic cancer	0.000218	0.124	CrCbGaD
Estradiol—ESR2—lung—hematologic cancer	0.000211	0.00727	CbGeAlD
Estradiol—CYP2C8—hematopoietic system—hematologic cancer	0.000205	0.00706	CbGeAlD
Estradiol—CYP1B1—gonad—hematologic cancer	0.000204	0.00701	CbGeAlD
Estradiol—AOX1—lung—hematologic cancer	0.000204	0.007	CbGeAlD
Estradiol—SLCO1C1—lymph node—hematologic cancer	0.000204	0.00699	CbGeAlD
Estradiol—SLC22A1—blood—hematologic cancer	0.000202	0.00695	CbGeAlD
Estradiol—ESR2—testis—hematologic cancer	0.0002	0.00686	CbGeAlD
Estradiol—ABCC10—lung—hematologic cancer	0.000198	0.00681	CbGeAlD
Estradiol—SHBG—testis—hematologic cancer	0.000194	0.00667	CbGeAlD
Estradiol—AR—gonad—hematologic cancer	0.000193	0.00664	CbGeAlD
Estradiol—CYP1A2—hematopoietic system—hematologic cancer	0.000192	0.00661	CbGeAlD
Estradiol—AOX1—testis—hematologic cancer	0.000192	0.0066	CbGeAlD
Estradiol—CYP1A1—hematopoietic system—hematologic cancer	0.00019	0.00652	CbGeAlD
Estradiol—ESR1—gonad—hematologic cancer	0.00019	0.00652	CbGeAlD
Estradiol—CYP3A4—Doxorubicin—hematologic cancer	0.000189	0.000576	CbGbCtD
Estradiol—ABCC10—testis—hematologic cancer	0.000187	0.00642	CbGeAlD
Estradiol—SLC22A8—blood—hematologic cancer	0.000186	0.00639	CbGeAlD
Estradiol—SLCO2B1—lung—hematologic cancer	0.000186	0.00638	CbGeAlD
Estradiol—CYP3A5—hematopoietic system—hematologic cancer	0.000185	0.00637	CbGeAlD
Estradiol—CYP2C9—hematopoietic system—hematologic cancer	0.000182	0.00627	CbGeAlD
Estradiol—CYP1B1—blood—hematologic cancer	0.000178	0.00611	CbGeAlD
Estradiol—SLCO2B1—testis—hematologic cancer	0.000175	0.00602	CbGeAlD
Estradiol—SLCO1A2—lung—hematologic cancer	0.000171	0.00587	CbGeAlD
Estradiol—SLC22A3—lung—hematologic cancer	0.000169	0.00582	CbGeAlD
Estradiol—AR—blood—hematologic cancer	0.000168	0.00578	CbGeAlD
Estradiol—ESR1—blood—hematologic cancer	0.000165	0.00568	CbGeAlD
Estradiol—SLCO4A1—lymph node—hematologic cancer	0.000163	0.0056	CbGeAlD
Estradiol—SLCO1A2—testis—hematologic cancer	0.000161	0.00554	CbGeAlD
Estradiol—ALB—testis—hematologic cancer	0.00016	0.00551	CbGeAlD
Estradiol—SLC22A3—testis—hematologic cancer	0.00016	0.0055	CbGeAlD
Estradiol—CYP2C19—blood—hematologic cancer	0.000156	0.00536	CbGeAlD
Estradiol—CYP1B1—lung—hematologic cancer	0.000156	0.00535	CbGeAlD
Estradiol—AR—lung—hematologic cancer	0.000148	0.00507	CbGeAlD
Estradiol—Quinestrol—ESR1—hematologic cancer	0.000147	0.0835	CrCbGaD
Estradiol—CYP1B1—testis—hematologic cancer	0.000147	0.00505	CbGeAlD
Estradiol—ESR1—lung—hematologic cancer	0.000145	0.00498	CbGeAlD
Estradiol—ESR2—lymph node—hematologic cancer	0.000145	0.00497	CbGeAlD
Estradiol—AOX1—lymph node—hematologic cancer	0.000139	0.00478	CbGeAlD
Estradiol—AR—testis—hematologic cancer	0.000139	0.00478	CbGeAlD
Estradiol—CYP3A4—hematopoietic system—hematologic cancer	0.000139	0.00478	CbGeAlD
Estradiol—Drostanolone—AR—hematologic cancer	0.000138	0.0784	CrCbGaD
Estradiol—ESR1—testis—hematologic cancer	0.000137	0.0047	CbGeAlD
Estradiol—CYP2C8—blood—hematologic cancer	0.000136	0.00468	CbGeAlD
Estradiol—ABCC10—lymph node—hematologic cancer	0.000136	0.00466	CbGeAlD
Estradiol—ABCG2—blood—hematologic cancer	0.000132	0.00455	CbGeAlD
Estradiol—ABCG2—bone marrow—hematologic cancer	0.000128	0.0044	CbGeAlD
Estradiol—CYP1A2—blood—hematologic cancer	0.000127	0.00438	CbGeAlD
Estradiol—SLCO2B1—lymph node—hematologic cancer	0.000127	0.00436	CbGeAlD
Estradiol—CYP1A1—blood—hematologic cancer	0.000126	0.00432	CbGeAlD
Estradiol—CYP3A5—blood—hematologic cancer	0.000123	0.00422	CbGeAlD
Estradiol—CYP2C9—blood—hematologic cancer	0.000121	0.00415	CbGeAlD
Estradiol—ALB—lymph node—hematologic cancer	0.000116	0.00399	CbGeAlD
Estradiol—ABCG2—lung—hematologic cancer	0.000116	0.00399	CbGeAlD
Estradiol—SLC22A3—lymph node—hematologic cancer	0.000116	0.00398	CbGeAlD
Estradiol—CYP2C8—testis—hematologic cancer	0.000113	0.00387	CbGeAlD
Estradiol—CYP1A2—lung—hematologic cancer	0.000112	0.00384	CbGeAlD
Estradiol—Mestranol—ESR1—hematologic cancer	0.000112	0.0633	CrCbGaD
Estradiol—Trilostane—ESR1—hematologic cancer	0.000112	0.0633	CrCbGaD
Estradiol—CYP1A1—lung—hematologic cancer	0.00011	0.00378	CbGeAlD
Estradiol—ABCG2—testis—hematologic cancer	0.000109	0.00376	CbGeAlD
Estradiol—Estropipate—SLC22A1—hematologic cancer	0.000109	0.0617	CrCbGaD
Estradiol—CYP3A5—lung—hematologic cancer	0.000108	0.0037	CbGeAlD
Estradiol—CYP1B1—lymph node—hematologic cancer	0.000107	0.00366	CbGeAlD
Estradiol—AR—lymph node—hematologic cancer	0.000101	0.00347	CbGeAlD
Estradiol—ESR1—lymph node—hematologic cancer	9.91e-05	0.0034	CbGeAlD
Estradiol—ABCB1—hematopoietic system—hematologic cancer	9.85e-05	0.00338	CbGeAlD
Estradiol—Conjugated Estrogens—ABCC3—hematologic cancer	9.77e-05	0.0554	CrCbGaD
Estradiol—Estriol—ESR1—hematologic cancer	9.74e-05	0.0552	CrCbGaD
Estradiol—CYP3A4—blood—hematologic cancer	9.22e-05	0.00317	CbGeAlD
Estradiol—Estramustine—ESR1—hematologic cancer	9.06e-05	0.0514	CrCbGaD
Estradiol—ABCG2—lymph node—hematologic cancer	7.93e-05	0.00273	CbGeAlD
Estradiol—CYP1A1—lymph node—hematologic cancer	7.53e-05	0.00259	CbGeAlD
Estradiol—ABCB1—gonad—hematologic cancer	7.49e-05	0.00257	CbGeAlD
Estradiol—Estropipate—ESR1—hematologic cancer	7.45e-05	0.0422	CrCbGaD
Estradiol—ABCB1—blood—hematologic cancer	6.53e-05	0.00224	CbGeAlD
Estradiol—ABCB1—bone marrow—hematologic cancer	6.31e-05	0.00217	CbGeAlD
Estradiol—ABCB1—lung—hematologic cancer	5.72e-05	0.00197	CbGeAlD
Estradiol—ABCB1—testis—hematologic cancer	5.4e-05	0.00185	CbGeAlD
Estradiol—Ethinyl Estradiol—ESR1—hematologic cancer	5.32e-05	0.0302	CrCbGaD
Estradiol—Conjugated Estrogens—ABCG2—hematologic cancer	4.75e-05	0.0269	CrCbGaD
Estradiol—Estrone—ABCG2—hematologic cancer	4.73e-05	0.0268	CrCbGaD
Estradiol—Conjugated Estrogens—ESR1—hematologic cancer	4.65e-05	0.0264	CrCbGaD
Estradiol—Estrone—ESR1—hematologic cancer	4.64e-05	0.0263	CrCbGaD
Estradiol—Estriol—ABCB1—hematologic cancer	4.14e-05	0.0235	CrCbGaD
Estradiol—Testosterone—SLC22A1—hematologic cancer	4.12e-05	0.0234	CrCbGaD
Estradiol—ABCB1—lymph node—hematologic cancer	3.91e-05	0.00134	CbGeAlD
Estradiol—Estramustine—ABCB1—hematologic cancer	3.85e-05	0.0218	CrCbGaD
Estradiol—Testosterone—AR—hematologic cancer	3.66e-05	0.0207	CrCbGaD
Estradiol—Estropipate—ALB—hematologic cancer	3.32e-05	0.0188	CrCbGaD
Estradiol—Testosterone—ABCG2—hematologic cancer	2.88e-05	0.0163	CrCbGaD
Estradiol—Ethinyl Estradiol—ABCB1—hematologic cancer	2.26e-05	0.0128	CrCbGaD
Estradiol—Estrone—ALB—hematologic cancer	2.06e-05	0.0117	CrCbGaD
Estradiol—Conjugated Estrogens—ABCB1—hematologic cancer	1.98e-05	0.0112	CrCbGaD
Estradiol—Estrone—ABCB1—hematologic cancer	1.97e-05	0.0112	CrCbGaD
Estradiol—Testosterone—ALB—hematologic cancer	1.25e-05	0.00712	CrCbGaD
Estradiol—Testosterone—ABCB1—hematologic cancer	1.2e-05	0.00679	CrCbGaD
Estradiol—Tachycardia—Prednisone—hematologic cancer	5.4e-06	4.89e-05	CcSEcCtD
Estradiol—Alopecia—Epirubicin—hematologic cancer	5.39e-06	4.87e-05	CcSEcCtD
Estradiol—Skin disorder—Prednisone—hematologic cancer	5.38e-06	4.87e-05	CcSEcCtD
Estradiol—Nausea—Gemcitabine—hematologic cancer	5.37e-06	4.86e-05	CcSEcCtD
Estradiol—Vomiting—Cisplatin—hematologic cancer	5.36e-06	4.85e-05	CcSEcCtD
Estradiol—Hyperhidrosis—Prednisone—hematologic cancer	5.35e-06	4.84e-05	CcSEcCtD
Estradiol—Mental disorder—Epirubicin—hematologic cancer	5.34e-06	4.83e-05	CcSEcCtD
Estradiol—Erythema multiforme—Doxorubicin—hematologic cancer	5.33e-06	4.83e-05	CcSEcCtD
Estradiol—Rash—Cisplatin—hematologic cancer	5.32e-06	4.81e-05	CcSEcCtD
Estradiol—Dermatitis—Cisplatin—hematologic cancer	5.31e-06	4.81e-05	CcSEcCtD
Estradiol—Erythema—Epirubicin—hematologic cancer	5.31e-06	4.8e-05	CcSEcCtD
Estradiol—Malnutrition—Epirubicin—hematologic cancer	5.31e-06	4.8e-05	CcSEcCtD
Estradiol—Diarrhoea—Etoposide—hematologic cancer	5.29e-06	4.78e-05	CcSEcCtD
Estradiol—Eye disorder—Doxorubicin—hematologic cancer	5.27e-06	4.77e-05	CcSEcCtD
Estradiol—Ill-defined disorder—Methotrexate—hematologic cancer	5.26e-06	4.76e-05	CcSEcCtD
Estradiol—Tinnitus—Doxorubicin—hematologic cancer	5.26e-06	4.76e-05	CcSEcCtD
Estradiol—Feeling abnormal—Betamethasone—hematologic cancer	5.24e-06	4.74e-05	CcSEcCtD
Estradiol—Feeling abnormal—Dexamethasone—hematologic cancer	5.24e-06	4.74e-05	CcSEcCtD
Estradiol—Flushing—Doxorubicin—hematologic cancer	5.23e-06	4.74e-05	CcSEcCtD
Estradiol—Cardiac disorder—Doxorubicin—hematologic cancer	5.23e-06	4.74e-05	CcSEcCtD
Estradiol—Flatulence—Epirubicin—hematologic cancer	5.23e-06	4.73e-05	CcSEcCtD
Estradiol—Tension—Epirubicin—hematologic cancer	5.21e-06	4.71e-05	CcSEcCtD
Estradiol—Gastrointestinal pain—Betamethasone—hematologic cancer	5.2e-06	4.71e-05	CcSEcCtD
Estradiol—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.2e-06	4.71e-05	CcSEcCtD
Estradiol—Dysgeusia—Epirubicin—hematologic cancer	5.2e-06	4.7e-05	CcSEcCtD
Estradiol—Hypersensitivity—Triamcinolone—hematologic cancer	5.16e-06	4.67e-05	CcSEcCtD
Estradiol—Nervousness—Epirubicin—hematologic cancer	5.15e-06	4.66e-05	CcSEcCtD
Estradiol—Back pain—Epirubicin—hematologic cancer	5.13e-06	4.64e-05	CcSEcCtD
Estradiol—Angiopathy—Doxorubicin—hematologic cancer	5.12e-06	4.63e-05	CcSEcCtD
Estradiol—Malaise—Methotrexate—hematologic cancer	5.11e-06	4.63e-05	CcSEcCtD
Estradiol—Dizziness—Etoposide—hematologic cancer	5.11e-06	4.62e-05	CcSEcCtD
Estradiol—Muscle spasms—Epirubicin—hematologic cancer	5.1e-06	4.62e-05	CcSEcCtD
Estradiol—Immune system disorder—Doxorubicin—hematologic cancer	5.09e-06	4.61e-05	CcSEcCtD
Estradiol—Vertigo—Methotrexate—hematologic cancer	5.09e-06	4.61e-05	CcSEcCtD
Estradiol—Mediastinal disorder—Doxorubicin—hematologic cancer	5.08e-06	4.6e-05	CcSEcCtD
Estradiol—Chills—Doxorubicin—hematologic cancer	5.06e-06	4.58e-05	CcSEcCtD
Estradiol—Urticaria—Dexamethasone—hematologic cancer	5.05e-06	4.57e-05	CcSEcCtD
Estradiol—Urticaria—Betamethasone—hematologic cancer	5.05e-06	4.57e-05	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.05e-06	4.57e-05	CcSEcCtD
Estradiol—Dizziness—Prednisolone—hematologic cancer	5.04e-06	4.56e-05	CcSEcCtD
Estradiol—Asthenia—Triamcinolone—hematologic cancer	5.03e-06	4.55e-05	CcSEcCtD
Estradiol—Abdominal pain—Dexamethasone—hematologic cancer	5.03e-06	4.55e-05	CcSEcCtD
Estradiol—Body temperature increased—Dexamethasone—hematologic cancer	5.03e-06	4.55e-05	CcSEcCtD
Estradiol—Body temperature increased—Betamethasone—hematologic cancer	5.03e-06	4.55e-05	CcSEcCtD
Estradiol—Abdominal pain—Betamethasone—hematologic cancer	5.03e-06	4.55e-05	CcSEcCtD
Estradiol—Nausea—Cisplatin—hematologic cancer	5.01e-06	4.53e-05	CcSEcCtD
Estradiol—Insomnia—Prednisone—hematologic cancer	5.01e-06	4.53e-05	CcSEcCtD
Estradiol—Alopecia—Doxorubicin—hematologic cancer	4.98e-06	4.51e-05	CcSEcCtD
Estradiol—Paraesthesia—Prednisone—hematologic cancer	4.97e-06	4.5e-05	CcSEcCtD
Estradiol—Pruritus—Triamcinolone—hematologic cancer	4.96e-06	4.49e-05	CcSEcCtD
Estradiol—Cough—Methotrexate—hematologic cancer	4.95e-06	4.48e-05	CcSEcCtD
Estradiol—Mental disorder—Doxorubicin—hematologic cancer	4.94e-06	4.47e-05	CcSEcCtD
Estradiol—Ill-defined disorder—Epirubicin—hematologic cancer	4.92e-06	4.46e-05	CcSEcCtD
Estradiol—Vomiting—Etoposide—hematologic cancer	4.91e-06	4.45e-05	CcSEcCtD
Estradiol—Erythema—Doxorubicin—hematologic cancer	4.91e-06	4.44e-05	CcSEcCtD
Estradiol—Malnutrition—Doxorubicin—hematologic cancer	4.91e-06	4.44e-05	CcSEcCtD
Estradiol—Agitation—Epirubicin—hematologic cancer	4.88e-06	4.41e-05	CcSEcCtD
Estradiol—Dyspepsia—Prednisone—hematologic cancer	4.87e-06	4.41e-05	CcSEcCtD
Estradiol—Rash—Etoposide—hematologic cancer	4.87e-06	4.41e-05	CcSEcCtD
Estradiol—Dermatitis—Etoposide—hematologic cancer	4.87e-06	4.4e-05	CcSEcCtD
Estradiol—Headache—Etoposide—hematologic cancer	4.84e-06	4.38e-05	CcSEcCtD
Estradiol—Flatulence—Doxorubicin—hematologic cancer	4.84e-06	4.38e-05	CcSEcCtD
Estradiol—Chest pain—Methotrexate—hematologic cancer	4.83e-06	4.37e-05	CcSEcCtD
Estradiol—Myalgia—Methotrexate—hematologic cancer	4.83e-06	4.37e-05	CcSEcCtD
Estradiol—Arthralgia—Methotrexate—hematologic cancer	4.83e-06	4.37e-05	CcSEcCtD
Estradiol—Tension—Doxorubicin—hematologic cancer	4.82e-06	4.36e-05	CcSEcCtD
Estradiol—Decreased appetite—Prednisone—hematologic cancer	4.81e-06	4.36e-05	CcSEcCtD
Estradiol—Dysgeusia—Doxorubicin—hematologic cancer	4.81e-06	4.35e-05	CcSEcCtD
Estradiol—Rash—Prednisolone—hematologic cancer	4.8e-06	4.35e-05	CcSEcCtD
Estradiol—Dermatitis—Prednisolone—hematologic cancer	4.8e-06	4.34e-05	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.79e-06	4.34e-05	CcSEcCtD
Estradiol—Malaise—Epirubicin—hematologic cancer	4.79e-06	4.33e-05	CcSEcCtD
Estradiol—Fatigue—Prednisone—hematologic cancer	4.77e-06	4.32e-05	CcSEcCtD
Estradiol—Headache—Prednisolone—hematologic cancer	4.77e-06	4.32e-05	CcSEcCtD
Estradiol—Discomfort—Methotrexate—hematologic cancer	4.77e-06	4.32e-05	CcSEcCtD
Estradiol—Nervousness—Doxorubicin—hematologic cancer	4.77e-06	4.32e-05	CcSEcCtD
Estradiol—Vertigo—Epirubicin—hematologic cancer	4.77e-06	4.31e-05	CcSEcCtD
Estradiol—Syncope—Epirubicin—hematologic cancer	4.76e-06	4.31e-05	CcSEcCtD
Estradiol—Back pain—Doxorubicin—hematologic cancer	4.75e-06	4.3e-05	CcSEcCtD
Estradiol—Constipation—Prednisone—hematologic cancer	4.74e-06	4.29e-05	CcSEcCtD
Estradiol—Muscle spasms—Doxorubicin—hematologic cancer	4.72e-06	4.27e-05	CcSEcCtD
Estradiol—Palpitations—Epirubicin—hematologic cancer	4.69e-06	4.24e-05	CcSEcCtD
Estradiol—Confusional state—Methotrexate—hematologic cancer	4.67e-06	4.22e-05	CcSEcCtD
Estradiol—Loss of consciousness—Epirubicin—hematologic cancer	4.66e-06	4.22e-05	CcSEcCtD
Estradiol—Dizziness—Triamcinolone—hematologic cancer	4.63e-06	4.19e-05	CcSEcCtD
Estradiol—Cough—Epirubicin—hematologic cancer	4.63e-06	4.19e-05	CcSEcCtD
Estradiol—Anaphylactic shock—Methotrexate—hematologic cancer	4.63e-06	4.19e-05	CcSEcCtD
Estradiol—Infection—Methotrexate—hematologic cancer	4.6e-06	4.16e-05	CcSEcCtD
Estradiol—Nausea—Etoposide—hematologic cancer	4.59e-06	4.15e-05	CcSEcCtD
Estradiol—Hypertension—Epirubicin—hematologic cancer	4.58e-06	4.15e-05	CcSEcCtD
Estradiol—Feeling abnormal—Prednisone—hematologic cancer	4.56e-06	4.13e-05	CcSEcCtD
Estradiol—Asthenia—Dexamethasone—hematologic cancer	4.56e-06	4.13e-05	CcSEcCtD
Estradiol—Asthenia—Betamethasone—hematologic cancer	4.56e-06	4.13e-05	CcSEcCtD
Estradiol—Ill-defined disorder—Doxorubicin—hematologic cancer	4.56e-06	4.12e-05	CcSEcCtD
Estradiol—Nervous system disorder—Methotrexate—hematologic cancer	4.54e-06	4.11e-05	CcSEcCtD
Estradiol—Gastrointestinal pain—Prednisone—hematologic cancer	4.53e-06	4.1e-05	CcSEcCtD
Estradiol—Nausea—Prednisolone—hematologic cancer	4.53e-06	4.1e-05	CcSEcCtD
Estradiol—Myalgia—Epirubicin—hematologic cancer	4.52e-06	4.09e-05	CcSEcCtD
Estradiol—Chest pain—Epirubicin—hematologic cancer	4.52e-06	4.09e-05	CcSEcCtD
Estradiol—Arthralgia—Epirubicin—hematologic cancer	4.52e-06	4.09e-05	CcSEcCtD
Estradiol—Agitation—Doxorubicin—hematologic cancer	4.51e-06	4.08e-05	CcSEcCtD
Estradiol—Anxiety—Epirubicin—hematologic cancer	4.5e-06	4.07e-05	CcSEcCtD
Estradiol—Pruritus—Dexamethasone—hematologic cancer	4.5e-06	4.07e-05	CcSEcCtD
Estradiol—Pruritus—Betamethasone—hematologic cancer	4.5e-06	4.07e-05	CcSEcCtD
Estradiol—Skin disorder—Methotrexate—hematologic cancer	4.5e-06	4.07e-05	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.49e-06	4.06e-05	CcSEcCtD
Estradiol—Hyperhidrosis—Methotrexate—hematologic cancer	4.47e-06	4.05e-05	CcSEcCtD
Estradiol—Discomfort—Epirubicin—hematologic cancer	4.46e-06	4.04e-05	CcSEcCtD
Estradiol—Vomiting—Triamcinolone—hematologic cancer	4.46e-06	4.03e-05	CcSEcCtD
Estradiol—Malaise—Doxorubicin—hematologic cancer	4.43e-06	4.01e-05	CcSEcCtD
Estradiol—Rash—Triamcinolone—hematologic cancer	4.42e-06	4e-05	CcSEcCtD
Estradiol—Dry mouth—Epirubicin—hematologic cancer	4.42e-06	4e-05	CcSEcCtD
Estradiol—Dermatitis—Triamcinolone—hematologic cancer	4.41e-06	3.99e-05	CcSEcCtD
Estradiol—Vertigo—Doxorubicin—hematologic cancer	4.41e-06	3.99e-05	CcSEcCtD
Estradiol—Syncope—Doxorubicin—hematologic cancer	4.4e-06	3.98e-05	CcSEcCtD
Estradiol—Urticaria—Prednisone—hematologic cancer	4.4e-06	3.98e-05	CcSEcCtD
Estradiol—Headache—Triamcinolone—hematologic cancer	4.39e-06	3.97e-05	CcSEcCtD
Estradiol—Abdominal pain—Prednisone—hematologic cancer	4.38e-06	3.96e-05	CcSEcCtD
Estradiol—Body temperature increased—Prednisone—hematologic cancer	4.38e-06	3.96e-05	CcSEcCtD
Estradiol—Confusional state—Epirubicin—hematologic cancer	4.37e-06	3.95e-05	CcSEcCtD
Estradiol—Diarrhoea—Betamethasone—hematologic cancer	4.35e-06	3.94e-05	CcSEcCtD
Estradiol—Diarrhoea—Dexamethasone—hematologic cancer	4.35e-06	3.94e-05	CcSEcCtD
Estradiol—Palpitations—Doxorubicin—hematologic cancer	4.34e-06	3.93e-05	CcSEcCtD
Estradiol—Anaphylactic shock—Epirubicin—hematologic cancer	4.33e-06	3.92e-05	CcSEcCtD
Estradiol—Oedema—Epirubicin—hematologic cancer	4.33e-06	3.92e-05	CcSEcCtD
Estradiol—Loss of consciousness—Doxorubicin—hematologic cancer	4.32e-06	3.91e-05	CcSEcCtD
Estradiol—Infection—Epirubicin—hematologic cancer	4.3e-06	3.89e-05	CcSEcCtD
Estradiol—Cough—Doxorubicin—hematologic cancer	4.28e-06	3.88e-05	CcSEcCtD
Estradiol—Shock—Epirubicin—hematologic cancer	4.26e-06	3.86e-05	CcSEcCtD
Estradiol—Nervous system disorder—Epirubicin—hematologic cancer	4.25e-06	3.84e-05	CcSEcCtD
Estradiol—Hypertension—Doxorubicin—hematologic cancer	4.24e-06	3.84e-05	CcSEcCtD
Estradiol—Tachycardia—Epirubicin—hematologic cancer	4.23e-06	3.82e-05	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.22e-06	3.82e-05	CcSEcCtD
Estradiol—Skin disorder—Epirubicin—hematologic cancer	4.21e-06	3.81e-05	CcSEcCtD
Estradiol—Dizziness—Dexamethasone—hematologic cancer	4.2e-06	3.8e-05	CcSEcCtD
Estradiol—Dizziness—Betamethasone—hematologic cancer	4.2e-06	3.8e-05	CcSEcCtD
Estradiol—Hyperhidrosis—Epirubicin—hematologic cancer	4.19e-06	3.79e-05	CcSEcCtD
Estradiol—Insomnia—Methotrexate—hematologic cancer	4.19e-06	3.79e-05	CcSEcCtD
Estradiol—Chest pain—Doxorubicin—hematologic cancer	4.18e-06	3.78e-05	CcSEcCtD
Estradiol—Myalgia—Doxorubicin—hematologic cancer	4.18e-06	3.78e-05	CcSEcCtD
Estradiol—Arthralgia—Doxorubicin—hematologic cancer	4.18e-06	3.78e-05	CcSEcCtD
Estradiol—Anxiety—Doxorubicin—hematologic cancer	4.17e-06	3.77e-05	CcSEcCtD
Estradiol—Nausea—Triamcinolone—hematologic cancer	4.16e-06	3.77e-05	CcSEcCtD
Estradiol—Paraesthesia—Methotrexate—hematologic cancer	4.16e-06	3.76e-05	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.15e-06	3.76e-05	CcSEcCtD
Estradiol—Discomfort—Doxorubicin—hematologic cancer	4.13e-06	3.74e-05	CcSEcCtD
Estradiol—Dyspnoea—Methotrexate—hematologic cancer	4.13e-06	3.73e-05	CcSEcCtD
Estradiol—Somnolence—Methotrexate—hematologic cancer	4.11e-06	3.72e-05	CcSEcCtD
Estradiol—Dry mouth—Doxorubicin—hematologic cancer	4.09e-06	3.7e-05	CcSEcCtD
Estradiol—Hypersensitivity—Prednisone—hematologic cancer	4.08e-06	3.69e-05	CcSEcCtD
Estradiol—Dyspepsia—Methotrexate—hematologic cancer	4.07e-06	3.69e-05	CcSEcCtD
Estradiol—Vomiting—Betamethasone—hematologic cancer	4.04e-06	3.66e-05	CcSEcCtD
Estradiol—Vomiting—Dexamethasone—hematologic cancer	4.04e-06	3.66e-05	CcSEcCtD
Estradiol—Confusional state—Doxorubicin—hematologic cancer	4.04e-06	3.66e-05	CcSEcCtD
Estradiol—Decreased appetite—Methotrexate—hematologic cancer	4.02e-06	3.64e-05	CcSEcCtD
Estradiol—Rash—Betamethasone—hematologic cancer	4.01e-06	3.63e-05	CcSEcCtD
Estradiol—Rash—Dexamethasone—hematologic cancer	4.01e-06	3.63e-05	CcSEcCtD
Estradiol—Oedema—Doxorubicin—hematologic cancer	4.01e-06	3.63e-05	CcSEcCtD
Estradiol—Anaphylactic shock—Doxorubicin—hematologic cancer	4.01e-06	3.63e-05	CcSEcCtD
Estradiol—Dermatitis—Dexamethasone—hematologic cancer	4.01e-06	3.62e-05	CcSEcCtD
Estradiol—Dermatitis—Betamethasone—hematologic cancer	4.01e-06	3.62e-05	CcSEcCtD
Estradiol—Gastrointestinal disorder—Methotrexate—hematologic cancer	4e-06	3.62e-05	CcSEcCtD
Estradiol—Fatigue—Methotrexate—hematologic cancer	3.99e-06	3.61e-05	CcSEcCtD
Estradiol—Headache—Dexamethasone—hematologic cancer	3.98e-06	3.6e-05	CcSEcCtD
Estradiol—Headache—Betamethasone—hematologic cancer	3.98e-06	3.6e-05	CcSEcCtD
Estradiol—Infection—Doxorubicin—hematologic cancer	3.98e-06	3.6e-05	CcSEcCtD
Estradiol—Asthenia—Prednisone—hematologic cancer	3.97e-06	3.6e-05	CcSEcCtD
Estradiol—Pain—Methotrexate—hematologic cancer	3.96e-06	3.58e-05	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.95e-06	3.57e-05	CcSEcCtD
Estradiol—Shock—Doxorubicin—hematologic cancer	3.94e-06	3.57e-05	CcSEcCtD
Estradiol—Nervous system disorder—Doxorubicin—hematologic cancer	3.93e-06	3.56e-05	CcSEcCtD
Estradiol—Pruritus—Prednisone—hematologic cancer	3.92e-06	3.55e-05	CcSEcCtD
Estradiol—Insomnia—Epirubicin—hematologic cancer	3.92e-06	3.54e-05	CcSEcCtD
Estradiol—Tachycardia—Doxorubicin—hematologic cancer	3.91e-06	3.54e-05	CcSEcCtD
Estradiol—Skin disorder—Doxorubicin—hematologic cancer	3.89e-06	3.52e-05	CcSEcCtD
Estradiol—Paraesthesia—Epirubicin—hematologic cancer	3.89e-06	3.52e-05	CcSEcCtD
Estradiol—Hyperhidrosis—Doxorubicin—hematologic cancer	3.87e-06	3.51e-05	CcSEcCtD
Estradiol—Dyspnoea—Epirubicin—hematologic cancer	3.86e-06	3.49e-05	CcSEcCtD
Estradiol—Somnolence—Epirubicin—hematologic cancer	3.85e-06	3.48e-05	CcSEcCtD
Estradiol—Feeling abnormal—Methotrexate—hematologic cancer	3.81e-06	3.45e-05	CcSEcCtD
Estradiol—Dyspepsia—Epirubicin—hematologic cancer	3.81e-06	3.45e-05	CcSEcCtD
Estradiol—Diarrhoea—Prednisone—hematologic cancer	3.79e-06	3.43e-05	CcSEcCtD
Estradiol—Gastrointestinal pain—Methotrexate—hematologic cancer	3.78e-06	3.42e-05	CcSEcCtD
Estradiol—Nausea—Betamethasone—hematologic cancer	3.78e-06	3.42e-05	CcSEcCtD
Estradiol—Nausea—Dexamethasone—hematologic cancer	3.78e-06	3.42e-05	CcSEcCtD
Estradiol—Decreased appetite—Epirubicin—hematologic cancer	3.76e-06	3.41e-05	CcSEcCtD
Estradiol—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.74e-06	3.38e-05	CcSEcCtD
Estradiol—Fatigue—Epirubicin—hematologic cancer	3.73e-06	3.38e-05	CcSEcCtD
Estradiol—Pain—Epirubicin—hematologic cancer	3.7e-06	3.35e-05	CcSEcCtD
Estradiol—Constipation—Epirubicin—hematologic cancer	3.7e-06	3.35e-05	CcSEcCtD
Estradiol—Urticaria—Methotrexate—hematologic cancer	3.68e-06	3.33e-05	CcSEcCtD
Estradiol—Dizziness—Prednisone—hematologic cancer	3.66e-06	3.31e-05	CcSEcCtD
Estradiol—Abdominal pain—Methotrexate—hematologic cancer	3.66e-06	3.31e-05	CcSEcCtD
Estradiol—Body temperature increased—Methotrexate—hematologic cancer	3.66e-06	3.31e-05	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.65e-06	3.3e-05	CcSEcCtD
Estradiol—Insomnia—Doxorubicin—hematologic cancer	3.62e-06	3.28e-05	CcSEcCtD
Estradiol—Paraesthesia—Doxorubicin—hematologic cancer	3.6e-06	3.26e-05	CcSEcCtD
Estradiol—Dyspnoea—Doxorubicin—hematologic cancer	3.57e-06	3.23e-05	CcSEcCtD
Estradiol—Feeling abnormal—Epirubicin—hematologic cancer	3.57e-06	3.23e-05	CcSEcCtD
Estradiol—Somnolence—Doxorubicin—hematologic cancer	3.56e-06	3.22e-05	CcSEcCtD
Estradiol—Gastrointestinal pain—Epirubicin—hematologic cancer	3.54e-06	3.2e-05	CcSEcCtD
Estradiol—Dyspepsia—Doxorubicin—hematologic cancer	3.53e-06	3.19e-05	CcSEcCtD
Estradiol—Vomiting—Prednisone—hematologic cancer	3.52e-06	3.19e-05	CcSEcCtD
Estradiol—Rash—Prednisone—hematologic cancer	3.49e-06	3.16e-05	CcSEcCtD
Estradiol—Dermatitis—Prednisone—hematologic cancer	3.49e-06	3.16e-05	CcSEcCtD
Estradiol—Decreased appetite—Doxorubicin—hematologic cancer	3.48e-06	3.15e-05	CcSEcCtD
Estradiol—Headache—Prednisone—hematologic cancer	3.47e-06	3.14e-05	CcSEcCtD
Estradiol—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.46e-06	3.13e-05	CcSEcCtD
Estradiol—Fatigue—Doxorubicin—hematologic cancer	3.45e-06	3.13e-05	CcSEcCtD
Estradiol—Urticaria—Epirubicin—hematologic cancer	3.44e-06	3.11e-05	CcSEcCtD
Estradiol—Constipation—Doxorubicin—hematologic cancer	3.43e-06	3.1e-05	CcSEcCtD
Estradiol—Pain—Doxorubicin—hematologic cancer	3.43e-06	3.1e-05	CcSEcCtD
Estradiol—Abdominal pain—Epirubicin—hematologic cancer	3.42e-06	3.1e-05	CcSEcCtD
Estradiol—Body temperature increased—Epirubicin—hematologic cancer	3.42e-06	3.1e-05	CcSEcCtD
Estradiol—Hypersensitivity—Methotrexate—hematologic cancer	3.41e-06	3.09e-05	CcSEcCtD
Estradiol—Asthenia—Methotrexate—hematologic cancer	3.32e-06	3e-05	CcSEcCtD
Estradiol—Feeling abnormal—Doxorubicin—hematologic cancer	3.3e-06	2.99e-05	CcSEcCtD
Estradiol—Nausea—Prednisone—hematologic cancer	3.29e-06	2.98e-05	CcSEcCtD
Estradiol—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.28e-06	2.97e-05	CcSEcCtD
Estradiol—Pruritus—Methotrexate—hematologic cancer	3.27e-06	2.96e-05	CcSEcCtD
Estradiol—Hypersensitivity—Epirubicin—hematologic cancer	3.19e-06	2.89e-05	CcSEcCtD
Estradiol—Urticaria—Doxorubicin—hematologic cancer	3.18e-06	2.88e-05	CcSEcCtD
Estradiol—Abdominal pain—Doxorubicin—hematologic cancer	3.17e-06	2.87e-05	CcSEcCtD
Estradiol—Body temperature increased—Doxorubicin—hematologic cancer	3.17e-06	2.87e-05	CcSEcCtD
Estradiol—Diarrhoea—Methotrexate—hematologic cancer	3.17e-06	2.87e-05	CcSEcCtD
Estradiol—Asthenia—Epirubicin—hematologic cancer	3.11e-06	2.81e-05	CcSEcCtD
Estradiol—Pruritus—Epirubicin—hematologic cancer	3.06e-06	2.77e-05	CcSEcCtD
Estradiol—Dizziness—Methotrexate—hematologic cancer	3.06e-06	2.77e-05	CcSEcCtD
Estradiol—Diarrhoea—Epirubicin—hematologic cancer	2.96e-06	2.68e-05	CcSEcCtD
Estradiol—Hypersensitivity—Doxorubicin—hematologic cancer	2.95e-06	2.67e-05	CcSEcCtD
Estradiol—Vomiting—Methotrexate—hematologic cancer	2.94e-06	2.66e-05	CcSEcCtD
Estradiol—Rash—Methotrexate—hematologic cancer	2.92e-06	2.64e-05	CcSEcCtD
Estradiol—Dermatitis—Methotrexate—hematologic cancer	2.92e-06	2.64e-05	CcSEcCtD
Estradiol—Headache—Methotrexate—hematologic cancer	2.9e-06	2.62e-05	CcSEcCtD
Estradiol—Asthenia—Doxorubicin—hematologic cancer	2.88e-06	2.6e-05	CcSEcCtD
Estradiol—Dizziness—Epirubicin—hematologic cancer	2.86e-06	2.59e-05	CcSEcCtD
Estradiol—Pruritus—Doxorubicin—hematologic cancer	2.84e-06	2.57e-05	CcSEcCtD
Estradiol—Vomiting—Epirubicin—hematologic cancer	2.75e-06	2.49e-05	CcSEcCtD
Estradiol—Nausea—Methotrexate—hematologic cancer	2.75e-06	2.49e-05	CcSEcCtD
Estradiol—Diarrhoea—Doxorubicin—hematologic cancer	2.74e-06	2.48e-05	CcSEcCtD
Estradiol—Rash—Epirubicin—hematologic cancer	2.73e-06	2.47e-05	CcSEcCtD
Estradiol—Dermatitis—Epirubicin—hematologic cancer	2.73e-06	2.47e-05	CcSEcCtD
Estradiol—Headache—Epirubicin—hematologic cancer	2.71e-06	2.46e-05	CcSEcCtD
Estradiol—Dizziness—Doxorubicin—hematologic cancer	2.65e-06	2.4e-05	CcSEcCtD
Estradiol—Nausea—Epirubicin—hematologic cancer	2.57e-06	2.33e-05	CcSEcCtD
Estradiol—Vomiting—Doxorubicin—hematologic cancer	2.55e-06	2.31e-05	CcSEcCtD
Estradiol—Rash—Doxorubicin—hematologic cancer	2.53e-06	2.29e-05	CcSEcCtD
Estradiol—Dermatitis—Doxorubicin—hematologic cancer	2.52e-06	2.28e-05	CcSEcCtD
Estradiol—Headache—Doxorubicin—hematologic cancer	2.51e-06	2.27e-05	CcSEcCtD
Estradiol—Nausea—Doxorubicin—hematologic cancer	2.38e-06	2.15e-05	CcSEcCtD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.92e-07	1.19e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CYCS—hematologic cancer	6.9e-07	1.19e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PTPN11—hematologic cancer	6.9e-07	1.19e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PTEN—hematologic cancer	6.88e-07	1.18e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—NCOR1—hematologic cancer	6.87e-07	1.18e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—GSTM1—hematologic cancer	6.87e-07	1.18e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—TGFB1—hematologic cancer	6.87e-07	1.18e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	6.86e-07	1.18e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—NCOR1—hematologic cancer	6.83e-07	1.18e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—GSTM1—hematologic cancer	6.83e-07	1.18e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—SLC22A1—hematologic cancer	6.83e-07	1.18e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CRABP1—hematologic cancer	6.83e-07	1.18e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PIK3R1—hematologic cancer	6.83e-07	1.18e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	6.8e-07	1.17e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.77e-07	1.17e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PIK3R1—hematologic cancer	6.77e-07	1.17e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PIK3R1—hematologic cancer	6.76e-07	1.16e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CREB1—hematologic cancer	6.69e-07	1.15e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GSTP1—hematologic cancer	6.67e-07	1.15e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3CD—hematologic cancer	6.67e-07	1.15e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ALOX5—hematologic cancer	6.66e-07	1.15e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—MTHFR—hematologic cancer	6.62e-07	1.14e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.62e-07	1.14e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—BRAF—hematologic cancer	6.6e-07	1.14e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—ALB—hematologic cancer	6.58e-07	1.13e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—EP300—hematologic cancer	6.56e-07	1.13e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCL2—hematologic cancer	6.54e-07	1.13e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL6R—hematologic cancer	6.52e-07	1.12e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GSTP1—hematologic cancer	6.51e-07	1.12e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CREBBP—hematologic cancer	6.51e-07	1.12e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.46e-07	1.11e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NUP98—hematologic cancer	6.45e-07	1.11e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PTEN—hematologic cancer	6.42e-07	1.11e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—KRAS—hematologic cancer	6.36e-07	1.1e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ABCB1—hematologic cancer	6.32e-07	1.09e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PIK3CB—hematologic cancer	6.3e-07	1.09e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3R1—hematologic cancer	6.3e-07	1.08e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.26e-07	1.08e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.26e-07	1.08e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PIK3CB—hematologic cancer	6.24e-07	1.08e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CD44—hematologic cancer	6.24e-07	1.07e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—NQO1—hematologic cancer	6.24e-07	1.07e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PIK3CB—hematologic cancer	6.24e-07	1.07e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MAP2K1—hematologic cancer	6.22e-07	1.07e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NUP214—hematologic cancer	6.21e-07	1.07e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3CD—hematologic cancer	6.18e-07	1.06e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.17e-07	1.06e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PIK3CA—hematologic cancer	6.17e-07	1.06e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GSTM1—hematologic cancer	6.13e-07	1.06e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—NCOR1—hematologic cancer	6.13e-07	1.06e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—EP300—hematologic cancer	6.12e-07	1.05e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—MAPK3—hematologic cancer	6.11e-07	1.05e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.11e-07	1.05e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ABCG2—hematologic cancer	6.09e-07	1.05e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—MTR—hematologic cancer	6.09e-07	1.05e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GSTP1—hematologic cancer	6.09e-07	1.05e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—MTHFR—hematologic cancer	6.07e-07	1.05e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PIK3CA—hematologic cancer	6.06e-07	1.04e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—MTHFR—hematologic cancer	6.04e-07	1.04e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—NCOR1—hematologic cancer	5.99e-07	1.03e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GSTM1—hematologic cancer	5.99e-07	1.03e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PTEN—hematologic cancer	5.98e-07	1.03e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ENO2—hematologic cancer	5.97e-07	1.03e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—MYC—hematologic cancer	5.95e-07	1.02e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—FGF2—hematologic cancer	5.91e-07	1.02e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYCS—hematologic cancer	5.9e-07	1.02e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CG—hematologic cancer	5.89e-07	1.01e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.89e-07	1.01e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PTEN—hematologic cancer	5.88e-07	1.01e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	5.86e-07	1.01e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—PIK3CA—hematologic cancer	5.85e-07	1.01e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.84e-07	1.01e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3R1—hematologic cancer	5.83e-07	1e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3CB—hematologic cancer	5.81e-07	1e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.79e-07	9.97e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ABCB1—hematologic cancer	5.76e-07	9.92e-06	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—EP300—hematologic cancer	5.71e-07	9.83e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—JAK2—hematologic cancer	5.67e-07	9.76e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—SDC1—hematologic cancer	5.66e-07	9.75e-06	CbGpPWpGaD
Estradiol—ALB—Hemostasis—TP53—hematologic cancer	5.65e-07	9.74e-06	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—EP300—hematologic cancer	5.61e-07	9.66e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—NCOR1—hematologic cancer	5.59e-07	9.63e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GSTM1—hematologic cancer	5.59e-07	9.63e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CG—hematologic cancer	5.57e-07	9.59e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MDM2—hematologic cancer	5.53e-07	9.53e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CREBBP—hematologic cancer	5.46e-07	9.41e-06	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PTEN—hematologic cancer	5.44e-07	9.38e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—MTHFR—hematologic cancer	5.42e-07	9.34e-06	CbGpPWpGaD
Estradiol—ALB—Hemostasis—HRAS—hematologic cancer	5.41e-07	9.31e-06	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PTEN—hematologic cancer	5.4e-07	9.29e-06	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PTEN—hematologic cancer	5.39e-07	9.28e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3CB—hematologic cancer	5.38e-07	9.27e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MTOR—hematologic cancer	5.38e-07	9.27e-06	CbGpPWpGaD
Estradiol—AR—Gene Expression—AKT1—hematologic cancer	5.35e-07	9.22e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.35e-07	9.22e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.32e-07	9.16e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—MTHFR—hematologic cancer	5.29e-07	9.11e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.28e-07	9.09e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GSTP1—hematologic cancer	5.2e-07	8.96e-06	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—EP300—hematologic cancer	5.19e-07	8.94e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CD—hematologic cancer	5.18e-07	8.92e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CREBBP—hematologic cancer	5.16e-07	8.89e-06	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—EP300—hematologic cancer	5.15e-07	8.86e-06	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—EP300—hematologic cancer	5.14e-07	8.85e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—ALB—hematologic cancer	5.11e-07	8.8e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CG—hematologic cancer	5.1e-07	8.79e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CG—hematologic cancer	5.07e-07	8.74e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CDKN1B—hematologic cancer	5.05e-07	8.7e-06	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—AKT1—hematologic cancer	5.04e-07	8.69e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.03e-07	8.67e-06	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PTEN—hematologic cancer	5.02e-07	8.65e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CASP3—hematologic cancer	4.95e-07	8.53e-06	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—AKT1—hematologic cancer	4.95e-07	8.53e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL2—hematologic cancer	4.94e-07	8.51e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—MTHFR—hematologic cancer	4.94e-07	8.51e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ABCB1—hematologic cancer	4.92e-07	8.48e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CD—hematologic cancer	4.89e-07	8.43e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3R1—hematologic cancer	4.89e-07	8.42e-06	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	4.85e-07	8.35e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—ALB—hematologic cancer	4.83e-07	8.32e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCND1—hematologic cancer	4.82e-07	8.3e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NQO1—hematologic cancer	4.81e-07	8.29e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CD44—hematologic cancer	4.81e-07	8.29e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—JUN—hematologic cancer	4.81e-07	8.28e-06	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—EP300—hematologic cancer	4.79e-07	8.25e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GSTM1—hematologic cancer	4.78e-07	8.23e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—NCOR1—hematologic cancer	4.78e-07	8.23e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.78e-07	8.23e-06	CbGpPWpGaD
Estradiol—ALB—Hemostasis—AKT1—hematologic cancer	4.78e-07	8.22e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CREBBP—hematologic cancer	4.73e-07	8.15e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—CREBBP—hematologic cancer	4.7e-07	8.1e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CDKN1A—hematologic cancer	4.66e-07	8.03e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PTEN—hematologic cancer	4.65e-07	8.01e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3R1—hematologic cancer	4.62e-07	7.96e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CG—hematologic cancer	4.55e-07	7.84e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYCS—hematologic cancer	4.55e-07	7.84e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MAPK8—hematologic cancer	4.55e-07	7.84e-06	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PIK3CA—hematologic cancer	4.53e-07	7.8e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.52e-07	7.79e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CB—hematologic cancer	4.51e-07	7.77e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CD—hematologic cancer	4.49e-07	7.73e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CD—hematologic cancer	4.46e-07	7.68e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CG—hematologic cancer	4.45e-07	7.66e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—EP300—hematologic cancer	4.44e-07	7.64e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—ALB—hematologic cancer	4.43e-07	7.63e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.36e-07	7.5e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—SRC—hematologic cancer	4.31e-07	7.43e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CB—hematologic cancer	4.26e-07	7.34e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3R1—hematologic cancer	4.24e-07	7.3e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—MTHFR—hematologic cancer	4.22e-07	7.27e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CREBBP—hematologic cancer	4.22e-07	7.27e-06	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PIK3CA—hematologic cancer	4.22e-07	7.27e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3R1—hematologic cancer	4.21e-07	7.25e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—VEGFA—hematologic cancer	4.2e-07	7.24e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—STAT3—hematologic cancer	4.16e-07	7.17e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CG—hematologic cancer	4.15e-07	7.15e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—NRAS—hematologic cancer	4.15e-07	7.15e-06	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	4.15e-07	7.14e-06	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—AKT1—hematologic cancer	4.12e-07	7.1e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CREBBP—hematologic cancer	4.12e-07	7.1e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.01e-07	6.91e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CD—hematologic cancer	4e-07	6.9e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MAPK3—hematologic cancer	3.97e-07	6.85e-06	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—AKT1—hematologic cancer	3.96e-07	6.82e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ALB—hematologic cancer	3.95e-07	6.81e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CB—hematologic cancer	3.91e-07	6.73e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CD—hematologic cancer	3.91e-07	6.73e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PTEN—hematologic cancer	3.9e-07	6.72e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CB—hematologic cancer	3.89e-07	6.7e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MYC—hematologic cancer	3.87e-07	6.66e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—ALB—hematologic cancer	3.86e-07	6.64e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TGFB1—hematologic cancer	3.86e-07	6.64e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CREBBP—hematologic cancer	3.85e-07	6.63e-06	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PIK3CA—hematologic cancer	3.84e-07	6.61e-06	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PIK3CA—hematologic cancer	3.81e-07	6.56e-06	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PIK3CA—hematologic cancer	3.8e-07	6.55e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.8e-07	6.54e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3R1—hematologic cancer	3.78e-07	6.51e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.72e-07	6.41e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—EP300—hematologic cancer	3.72e-07	6.41e-06	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—AKT1—hematologic cancer	3.7e-07	6.37e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3R1—hematologic cancer	3.69e-07	6.36e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.69e-07	6.35e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.69e-07	6.35e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PTEN—hematologic cancer	3.69e-07	6.35e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CD—hematologic cancer	3.65e-07	6.29e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ALB—hematologic cancer	3.6e-07	6.21e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—KRAS—hematologic cancer	3.57e-07	6.15e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CG—hematologic cancer	3.55e-07	6.11e-06	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3CA—hematologic cancer	3.54e-07	6.1e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—EP300—hematologic cancer	3.51e-07	6.05e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CB—hematologic cancer	3.49e-07	6.01e-06	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—AKT1—hematologic cancer	3.45e-07	5.94e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3R1—hematologic cancer	3.45e-07	5.94e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CB—hematologic cancer	3.41e-07	5.87e-06	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—AKT1—hematologic cancer	3.39e-07	5.84e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTEN—hematologic cancer	3.38e-07	5.82e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTEN—hematologic cancer	3.36e-07	5.79e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CREBBP—hematologic cancer	3.29e-07	5.67e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3CA—hematologic cancer	3.28e-07	5.65e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.26e-07	5.61e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—EP300—hematologic cancer	3.22e-07	5.55e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—EP300—hematologic cancer	3.2e-07	5.52e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.18e-07	5.48e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TP53—hematologic cancer	3.17e-07	5.47e-06	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—AKT1—hematologic cancer	3.14e-07	5.4e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CD—hematologic cancer	3.12e-07	5.37e-06	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—AKT1—hematologic cancer	3.11e-07	5.36e-06	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—AKT1—hematologic cancer	3.11e-07	5.35e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ALB—hematologic cancer	3.08e-07	5.3e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—HRAS—hematologic cancer	3.04e-07	5.23e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTEN—hematologic cancer	3.02e-07	5.19e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.95e-07	5.07e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTEN—hematologic cancer	2.94e-07	5.07e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL6—hematologic cancer	2.91e-07	5e-06	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—AKT1—hematologic cancer	2.89e-07	4.98e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—EP300—hematologic cancer	2.88e-07	4.95e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—EP300—hematologic cancer	2.81e-07	4.83e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CA—hematologic cancer	2.75e-07	4.74e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTEN—hematologic cancer	2.75e-07	4.74e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.74e-07	4.72e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.72e-07	4.68e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—AKT1—hematologic cancer	2.68e-07	4.62e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—EP300—hematologic cancer	2.62e-07	4.52e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CA—hematologic cancer	2.6e-07	4.48e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.54e-07	4.37e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.41e-07	4.15e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CA—hematologic cancer	2.38e-07	4.1e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ALB—hematologic cancer	2.38e-07	4.09e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CA—hematologic cancer	2.37e-07	4.08e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTEN—hematologic cancer	2.35e-07	4.05e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.27e-07	3.92e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—AKT1—hematologic cancer	2.25e-07	3.87e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—EP300—hematologic cancer	2.24e-07	3.86e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CA—hematologic cancer	2.13e-07	3.66e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—AKT1—hematologic cancer	2.12e-07	3.66e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.1e-07	3.61e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CA—hematologic cancer	2.08e-07	3.58e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—AKT1—hematologic cancer	1.95e-07	3.35e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.94e-07	3.34e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—AKT1—hematologic cancer	1.94e-07	3.33e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTEN—hematologic cancer	1.81e-07	3.12e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—AKT1—hematologic cancer	1.74e-07	2.99e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—EP300—hematologic cancer	1.73e-07	2.98e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—AKT1—hematologic cancer	1.7e-07	2.92e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.66e-07	2.85e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—AKT1—hematologic cancer	1.58e-07	2.73e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—AKT1—hematologic cancer	1.35e-07	2.33e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.28e-07	2.2e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—AKT1—hematologic cancer	1.05e-07	1.8e-06	CbGpPWpGaD
